PROVIDER PROFILE · NPI 1063488138
Sameer MathurMD PHD
PRESCRIBING · PART D · 2024
Total Rx claims
917
Beneficiaries
—
Total drug cost
$978K
Distinct drugs
26
Brand share
55.4%
Top prescribed drugs
Fluticasone Propionate101 claims
Albuterol Sulfate76 claims
Montelukast Sodium64 claims
Ipratropium Bromide54 claims
Fluticasone/Vilanterol50 claims
QUALITY · MIPS · 2024
Final MIPS score
83.3
Quality
87.8
Cost
75.8
Improvement activities
40.0
Promoting interop.
77.0
Payment adjustment
0.35%
Group
REFERRAL NETWORK
Where Sameer Mathur's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 1 outbound destinations.
Receives referrals from
Inbound — who sends patients here
No inbound pairs above the suppression threshold.
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| UNIVERSITY OF WISCONSIN HOSPITALS AND CLINICS AUTHORITY | 132 | 1,825 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE